Laminin isoform profiles in salivary glands in Sjögren's syndrome

Advances in Clinical Chemistry

Volumn 55, Issue , 2011, Pages 35-59

  Porola, Pauliina ^a,b   Mackiewicz, Zygmunt ^c,d   Laine, Mikael ^a,b   Baretto, Gonçalo ^b,e   Stegaev, Vasily ^a,b   Takakubo, Yuya ^b,g   Takagi, Michiaki ^f   Ainola, Mari ^a,b   Konttinen, Yrjö T ^a,g,h  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c State Research Institute Center for Innovative Medicine   (Lithuania)

^d MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

^e UNIVERSITY OF PORTO   (Portugal)

^f YAMAGATA UNIVERSITY   (Japan)

^g ORTON ORTHOPAEDIC HOSPITAL   (Finland)

^h ORTON Orthopedic Hospital of the ORTON Foundation ^*  (Finland)

Author keywords

Basement membrane; Integrin; Labial salivary glands; Laminins; Sj gren's syndrome

Indexed keywords

EID: 80052648055     PISSN: 00652423     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-387042-1.00003-4     Document Type: Chapter

References (87)

1. Segerberg-Konttinen M., Konttinen Y.T., Bergroth V. Focus score in the diagnosis of Sjögren's syndrome. Scand. J. Rheumatol. Suppl. 1986, 61:47-51.
2. Konttinen Y.T., Kulomaa M., Malmström M., Kilpi A., Reitamo S. Lactoferrin in Sjögren's syndrome. Arthritis Rheum. 1984, 27(4):462-467.
3. Saari H., Halinen S., Ganlöv K., Sorsa T., Konttinen Y.T. Salivary mucous glycoprotein MG1 in Sjögren's syndrome. Clin. Chim. Acta 1987, 259(1-2):83-96.
4. Konttinen Y.T., Vivó Porcar A., Porola P., et al. Neurobiology and hormonal control of lacrimal and salivary gland function. Sjögren's Syndrome 2011, Humana Press, New York, USA. R. Fox (Ed.).
5. Koski H., Janin A., Humphreys-Beher M.G., Sorsa T., Malmström M., Konttinen Y.T. Tumor necrosis factor-alpha and receptors for it in labial salivary glands in Sjögren's syndrome. Clin. Exp. Rheumatol. 2001, 19(2):131-137.
6. Konttinen Y.T. In situ characterization of the cellular infiltrate in labial and palatine glands in Sjögren's syndrome. Scand. J. Rheumatol. 1981, 10(4):321-330.
7. Segerberg-Konttinen M., Bergroth V., Jungell P., et al. T lymphocyte activation state in the minor salivary glands of patients with Sjögren's syndrome. Ann. Rheum. Dis. 1987, 46(9):649-653.
8. Aumailley M., Smyth N. The role of the laminins in basement membrane function. J. Anat. 1998, 193:1-21.
9. Ekblom M., Falk M., Salmivirta K., Durbeej M., Ekblom P. Laminin isoforms and epithelial development. Ann. N. Y. Acad. Sci. 1998, 857:194-211.
10. Yurchenco P.D., Amenta P.S., Patton B.L. Basement membrane assembly, stability and activities observed through a developmental lens. Matrix Biol. 2004, 22(7):521-538.
11. Fox J.W., Mayer U., Nischt R., et al. Recombinant nidogen consists of three globular domains and mediates binding of laminin to collagen type IV. EMBO J. 1991, 10(11):3137-3146.
12. Kohfeldt E., Sasaki T., Gohring W., Timpl R. Nidogen-2: a new basement membrane protein with diverse binding properties. J. Mol. Biol. 1998, 282(1):99-109.
13. Gohring W., Sasaki T., Heldin C.H., Timpl R. Mapping of the binding of platelet-derived growth factor to distinct domains of the basement membrane proteins BM-40 and perlecan and distinction from the BM-40 collagen-binding epitope. Eur. J. Biochem. 1998, 255(1):60-66.
14. Laine M., Virtanen I., Salo T., Konttinen Y.T. Segment-specific but pathologic laminin isoform profiles in human labial salivary glands of patients with Sjögren's. syndrome. Arthritis Rheum. 2004, 50(12):3968-3973.
15. Aumailley M., Bruckner-Tuderman L., Carter W.G., et al. A simplified laminin nomenclature. Matrix Biol. 2005, 24(5):326-332.
16. Byström B., Virtanen I., Rousselle P., Gullberg D., Pedrosa-Domellöf F. Distribution of laminins in the developing human eye. Invest. Ophthalmol. Vis. Sci. 2006, 47(3):777-785.
17. Patarroyo M., Tryggvason K., Virtanen I. Laminin isoforms in tumor invasion, angiogenesis and metastasis. Semin. Cancer Biol. 2002, 12(3):197-207.
18. Tzu J., Marinkovich M.P. Bridging structure with function: structural, regulatory, and developmental role of laminins. Int. J. Biochem. Cell Biol. 2008, 40:199-214.
19. Durbeej M. Laminins. Cell Tissue Res. 2010, 339(1):259-268.
20. Porola P., Laine M., Virtanen I., Pöllänen R., Przybyla B., Konttinen Y.T. Androgens and integrins in salivary glands in Sjögren's syndrome. J. Rheumatol. 2010, 37(6):1181-1187.
21. Strassburger S., Berndt A., Hyckel P., Katenkamp D., Kosmehl H. Differential expression of laminin chains in the human major salivary gland. Histochem. J. 1998, 30(2):81-88.
22. Engvall E., Davis G.E., Dickerson K., Ruoslahti E., Varon S., Manthorpe M. Mapping of domains in human laminin using monoclonal antibodies: localization of the neurite-promoting site. J. Cell Biol. 1986, 103(6 pt 1):2457-2465.
23. Tiger C.F., Chapliaud M.F., Pedrosa-Domellof F., Thornell L.E., Ekblom P., Gullberg D. Presence of laminin α5 chain and lack of laminin α1 chain during human muscle development and in muscular dystrophies. J. Biol. Chem. 1997, 272(45):28590-28595.
24. Virtanen I., Gullberg D., Rissanen J., et al. Laminin α1-chain shows a restricted distribution in epithelial basement membranes of fetal and adult human tissues. Exp. Cell Res. 2000, 257(2):298-309.
25. Kishi T., Takao T., Fujita L., Taniguchi H. Clonal proliferation of multipotent stem/progenitor cells in the neonatal and adult salivary glands. Biochem. Biophys. Res. Commun. 2006, 340(2):544-552.
26. Royce L.S., Kibbey M.C., Mertz P., Kleinman H.K., Baum B.J. Human neoplastic submandibular intercalated duct cells express an acinar phenotype when cultured on a basement membrane matrix. Differentiation 1993, 52(3):247-255.
27. Colognato H., Yurchenco P.D. Form and function: the laminin family of heterotrimers. Dev. Dyn. 2000, 218(2):213-234.
28. Poduval P., Sillat T., Virtanen I., Dabagh-Meshin M., Konttinen Y.T. Immigration check for neutrophils in RA lining: laminin α5 low expression regions act as exit points. Scand. J. Rheumatol. 2010, 39(2):132-140.
29. McArthur C.P., Fox N.W., Kragel P. Monoclonal antibody detection of laminin in minor salivary glands of patients with Sjogren's syndrome. J. Autoimmun. 1993, 6(5):649-661.
30. Petäjäniemi N., Korhonen M., Kortesmaa J., et al. Localization of laminin α4-chain in developing and adult human tissues. J. Histochem. Cytochem. 2002, 50(8):1113-1130.
31. Kwon Y.J., Pérez P., Aguilera S., et al. Involvement of specific laminins and nidogens in the active remodeling of the basal lamina of labial salivary glands from patients with Sjögren's syndrome. Arthritis Rheum. 2006, 54(11):3465-3475.
32. Velozo J., Aguilera S., Alliende C., et al. Severe alterations in expression and localisation of α6β4 integrin in salivary gland acini from patients with Sjogren syndrome. Ann. Rheum. Dis. 2009, 68(6):991-996.
33. Molina C., Alliende C., Aguilera S., et al. Basal lamina disorganisation of the acini and ducts of labial salivary glands from patients with Sjogren's syndrome: association with mononuclear cell infiltration. Ann. Rheum. Dis. 2006, 65(2):178-183.
34. Spaan M., Porola P., Laine M., Rozman B., Azuma M., Konttinen Y.T. Healthy human salivary glands contain a DHEA-sulphate processing intracrine machinery, which is deranged in primary Sjögren's syndrome. J. Cell. Mol. Med. 2009, 13(7):1261-1270.
35. Porola P., Virkki L., Przybyla B.D., et al. Androgen deficiency and defective intracrine processing of DHEA in the salivary glands in Sjögren's syndrome. J. Rheumatol. 2008, 35(11):2229-2235.
36. Nishiuchi R., Takagi J., Hayashi M., et al. Ligand-binding specificities of laminin-binding integrins: a comprehensive survey of laminin-integrin interactions using recombinant alpha3beta1, alpha6beta1, alpha7beta1 and alpha6beta4 integrins. Matrix Biol. 2006, 25(3):189-197.
37. Givant-Horwitz V., Davidson B., Reich R. Laminin-induced signaling in tumor cells. Cancer Lett. 2005, 223(1):1-10.
38. Nykvist P. Integrins as cellular receptors for fibril-forming and transmembrane collagens 2004, Doctoral dissertation., 1-127.
39. Parsons S.F., Lee G., Spring F.A., et al. Lutheran blood group glycoprotein and its newly characterized mouse homologue specifically bind alpha5 chain-containing human laminin with high affinity. Blood 2001, 97(1):312-320.
40. Winder S.J. The complexities of dystroglycan. Trends Biochem. Sci. 2001, 26(2):118-124.
41. Kikkawa Y., Miner J.H. Review: Lutheran/B-CAM: a laminin receptor on red blood cells and various tissues. Connect. Tissue Res. 2005, 46(4-5):193-199.
42. Sasaki T., Timpl R. Domain IVa of laminin alpha5 chain is cell-adhesive and binds beta1 and alphaVbeta3 integrins through Arg-Gly-Asp. FEBS Lett. 2001, 509(2):181-185.
43. Ido H., Ito S., Taniguchi Y., et al. Laminin isoforms containing the gamma3 chain are unable to bind to integrins due to the absence of the glutamic acid residue conserved in the C-terminal regions of the gamma1 and gamma2 chains. J. Biol. Chem. 2008, 283(42):28149-28157.
44. Laine M., Virtanen I., Porola P., et al. Acinar epithelial cell laminin-receptors in labial salivary glands in Sjögren's syndrome. Clin. Exp. Rheumatol. 2008, 26:807-813.
45. Yang C.W., Hattori M., Vlassara H., et al. Overexpression of transforming growth factor-beta 1 mRNA is associated with up-regulation of glomerular tenascin and laminin gene expression in nonobese diabetic mice. J. Am. Soc. Nephrol. 1995, 5(8):1610-1617.
46. Koski H., Konttinen Y.T., Xu-Hong G., Hietanen J., Malmström M. Transforming growth factor β2 in labial salivary glands in Sjögren's syndrome. Ann. Rheum. Dis. 1995, 54(9):744-747.
47. Roescher N., Tak P.P., Illei G.G. Cytokines in Sjögren's syndrome. Oral Dis. 2009, 15(8):519-526.
48. Daniels P.J., McArthur C.P., Heruth D.P., Rothberg P.G., Pasztor L., Wang Y. Cytokine-mediated stimulation of laminin expression and cell-growth arrest in a human submandibular gland duct-cell line (HSG). Arch. Oral Biol. 1999, 44(7):603-615.
49. Lamers M.L., Gimenes F.A., Nogueira F.N., Nicolau J., Gama P., Santos M.F. Chronic hyperglycaemia increases TGFbeta2 signaling and the expression of extracellular matrix proteins in the rat parotid gland. Matrix Biol. 2007, 26(7):572-582.
50. Armanet M., Wojtusciszyn A., Morel P., et al. Regulated laminin-332 expression in human islets of Langerhans. FASEB J. 2009, 23(12):4046-4055.
51. Richardson C.A., Gordon K.L., Couser W.G., Bomsztyk K. IL-1 beta increases laminin B2 chain mRNA levels and activates NF-kappa B in rat glomerular epithelial cells. Am. J. Physiol. 1995, 268(2 Pt. 2):F273-F278.
52. Korang K., Christiano A.M., Uitto J., Mauviel A. Differential cytokine modulation of the genes LAMA3, LAMB3, and LAMC2, encoding the constitutive polypeptides, alpha 3, beta 3, and gamma 2, of human laminin 5 in epidermal keratinocytes. FEBS Lett. 1995, 368(3):556-558.
53. Furuyama A., Iwata M., Hayashi T., Mochitate K. Transforming growth factor-beta1 regulates basement membrane formation by alveolar epithelial cells in vitro. Eur. J. Cell Biol. 1999, 78(12):867-875.
54. Neubauer K., Krüger M., Quondamatteo F., Knittel T., Saile B., Ramadori G. Transforming growth factor-beta1 stimulates the synthesis of basement membrane proteins laminin, collagen type IV and entactin in rat liver sinusoidal endothelial cells. J. Hepatol. 1999, 31(4):692-702.
55. Olsen J., Kirkeby L.T., Brorsson M.M., et al. Converging signals synergistically activate the LAMC2 promoter and lead to accumulation of the laminin gamma 2 chain in human colon carcinoma cells. Biochem. J. 2003, 371(Pt. 1):211-221.
56. Furuyama A., Hosokawa T., Mochitate K. Interleukin-1beta and tumor necrosis factor-alpha have opposite effects on fibroblasts and epithelial cells during basement membrane formation. Matrix Biol. 2008, 27(5):429-440.
57. Vasios G.W., Gold J.D., Petkovich M., Chambon P., Gudas L.J. A retinoic acid-responsive element is present in the 5' flanking region of the laminin B1 gene. Proc. Natl. Acad. Sci. USA 1989, 86(23):9099-9103.
58. Chang H.S., Kim N.B., Philips S.L. Positive elements in the laminin γ1 gene synergize to activate high level transcription during cellular differentiation. Nucleic Acids Res. 1996, 24(7):1360-1368.
59. Kedar V., Freese E., Hempel F.G. Regulatory sequences for the transcription of the laminin B2 gene in astrocytes. Brain Res. Mol. Brain Res. 1997, 47(1-2):87-98.
60. Higaki Y., Schullery D., Kawata Y., Shnyreva M., Abrass C., Bomsztyk K. Synergistic activation of the rat laminin gamma1 chain promoter by the gut-enriched Kruppel-like factor (GKLF/KLF4) and Sp1. Nucleic Acids Res. 2002, 30(11):2270-2279.
61. Talts J.F., Mann K., Yamada Y., Timpl R. Structural analysis and proteolytic processing of recombinant G domain of mouse laminin alpha2 chain. FEBS Lett. 1998, 426(1):71-76.
62. Tunggal P., Smyth N., Paulsson M., Ott M.C. Laminins: structure and genetic regulation. Microsc. Res. Tech. 2000, 51(3):214-227.
63. Hao J., McDaniel K., Weyer C., Barrera J., Nagle R.B. Cell line-specific translation of two laminin 5 beta3 chain isoforms. Gene 2002, 283(1-2):237-244.
64. Hayashi Y., Kim K.H., Fujiwara H., et al. Identification and recombinant production of human laminin alpha4 subunit splice variants. Biochem. Biophys. Res. Commun. 2002, 299(3):498-504.
65. Sathyanarayana U.G., Padar A., Huang C.X., et al. Aberrant promoter methylation and silencing of laminin-5-encoding genes in breast carcinoma. Clin. Cancer Res. 2003, 9(17):6389-6394.
66. Sathyanarayana U.G., Padar A., Suzuki M., et al. Aberrant promoter methylation of laminin-5-encoding genes in prostate cancers and its relationship to clinicopathological features. Clin. Cancer Res. 2003, 9(17):6395-6400.
67. Schneiders F.I., Maertens B., Böse K., et al. Binding of netrin-4 to laminin short arms regulates basement membrane assembly. J. Biol. Chem. 2007, 282(33):23750-23758.
68. McArthur C.P., Wang Y., Heruth D., Gustafson S. Amplification of extracellular matrix and oncogenes in tat-transfected human salivary gland cell lines with expression of laminin, fibronectin, collagens I, III, IV, c-myc and p53. Arch. Oral Biol. 2001, 46(6):545-555.
69. Kleinman H.K., Ebihara I., Killen P.D., et al. Genes for basement membrane proteins are coordinately expressed in differentiating F9 cells but not in normal adult murine tissues. Dev. Biol. 1987, 122(2):373-378.
70. Chang Y.C., Kao Y.H., Hu D.N., Tsai L.Y., Wu W.C. All-trans retinoic acid remodels extracellular matrix and suppresses laminin-enhanced contractility of cultured human retinal pigment epithelial cells. Exp. Eye Res. 2009, 88(5):900-909.
71. Valtysdóttir S.T., Wide L., Hällgren R. Low serum dehydroepiandrosterone sulfate in women with primary Sjögren's syndrome as an isolated sign of impaired HPA axis function. J. Rheumatol. 2001, 28(6):1259-1265.
72. Dixon A., Maric C. 17beta-Estradiol attenuates diabetic kidney disease by regulating extracellular matrix and transforming growth factor-beta protein expression and signaling. Am. J. Physiol. Renal Physiol. 2007, 293(5):F1678-F1690.
73. Soldano S., Montagna P., Brizzolara R., et al. Effects of estrogens on extracellular matrix synthesis in cultures of human normal and scleroderma skin fibroblasts. Ann. N. Y. Acad. Sci. 2010, 1193(1):25-29.
74. Nelson K., Helmstaedter V., Moreau C., Lage H. Estradiol, tamoxifen and ICI 182,780 alter alpha3 and beta1 integrin expression and laminin-1 adhesion in oral squamous cell carcinoma cell cultures. Oral Oncol. 2008, 44(1):94-99.
75. Cid M.C., Esparza J., Schnaper H.W., et al. Estradiol enhances endothelial cell interactions with extracellular matrix proteins via an increase in integrin expression and function. Angiogenesis 1999, 3(3):271-280.
76. Lindberg K., Ström A., Lock J.G., Gustafsson J.A., Haldosén L.A., Helguero L.A. Expression of estrogen receptor beta increases integrin alpha1 and integrin beta1 levels and enhances adhesion of breast cancer cells. J. Cell. Physiol. 2010, 222(1):156-167.
77. Walsh M.J., LeLeiko N.S., Sterling K.M. Regulation of types I, III, and IV procollagen mRNA synthesis in glucocorticoid-mediated intestinal development. J. Biol. Chem. 1987, 262(22):10814-10818.
78. Christie P.E., Jonas M., Tsai C.H., Chi E.Y., Henderson W.R. Increase in laminin expression in allergic airway remodelling and decrease by dexamethasone. Eur. Respir. J. 2004, 24(1):107-115.
79. Yurchenco P.D., Quan Y., Colognato H., et al. The alpha chain of laminin-1 is independently secreted and drives secretion of its beta- and gamma-chain partners. Proc. Natl. Acad. Sci. USA 1997, 94(19):10189-10194.
80. Konttinen Y.T., Kangaspunta P., Lindy O., et al. Collagenase in Sjögren's syndrome. Ann. Rheum. Dis. 1994, 53(12):836-839.
81. Konttinen Y.T., Halinen S., Hanemaaijer R., et al. Matrix metalloproteinase (MMP)-9 type IV collagenase/gelatinase implicated in the pathogenesis of Sjögren's syndrome. Matrix Biol. 1998, 17(5):335-347.
82. Hanemaaijer R., Visser H., Konttinen Y.T., Koolwijk P., Verheijen J.H. A novel and simple immunocapture assay for determination of gelatinase-B (MMP-9) activities in biological fluids: saliva from patients with Sjögren's syndrome contain increased latent and active gelatinase-B levels. Matrix Biol. 1998, 17(8-9):657-665.
83. Pérez P., Goicovich E., Alliende C., et al. Differential expression of matrix metalloproteinases in labial salivary glands of patients with primary Sjögren's syndrome. Arthritis Rheum. 2000, 43(12):2807-2817.
84. Pérez P., Kwon Y.J., Alliende C., et al. Increased acinar damage of salivary glands of patients with Sjögren's syndrome is paralleled by simultaneous imbalance of matrix metalloproteinase 3/tissue inhibitor of metalloproteinases 1 and matrix metalloproteinase 9/tissue inhibitor of metalloproteinases 1 ratios. Arthritis Rheum. 2005, 52(9):2751-2760.
85. Goicovich E., Molina C., Pérez P., et al. Enhanced degradation of proteins of the basal lamina and stroma by matrix metalloproteinases from the salivary glands of Sjögren's syndrome patients: correlation with reduced structural integrity of acini and ducts. Arthritis Rheum. 2003, 48(9):2573-2584.
86. Goldfinger L.E., Stack M.S., Jones J.C. Processing of laminin-5 and its functional consequences: role of plasmin and tissue-type plasminogen activator. J. Cell Biol. 1998, 141(1):255-265.
87. Virtanen T., Konttinen Y.T., Honkanen N., Härkönen M., Tervo T. Tear fluid plasmin activity of dry eye patients with Sjögren's syndrome. Acta Ophthalmol. Scand. 1997, 75(2):137-141.